Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesResults of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers
Clinical Therapeutics, 10/15/09
Makarounas–Kirchmann K et al. – In this meta–analysis, lercanidipine was associated with a lower risk of peripheral edema and a lower risk of treatment withdrawal because of peripheral edema than were the first–generation, but not the second–generation, dihydropyridine CCBs.
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding
Clinical Therapeutics, 11/02/09
The management of paracetamol poisoning
Paediatrics and Child Health, 11/09/09
Drugs for preventing malaria in travellers
Cochrane Reviews, 10/22/09
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09
Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/20/09
Sponsor
Article Search
Sponsor